#USA #Clinical Trials #Leesburg #Resonant Clinical Solutions #Labfish

Resonant Clinical Solutions Expands Global Equipment Footprint with Labfish Acquisition

In a significant move to enhance its clinical solutions offerings, Resonant Clinical Solutions has announced the acquisition of Labfish, a company known for its comprehensive laboratory rental solutions based in Germany. This strategic purchase represents a notable expansion of Resonant's global presence, particularly in the European market.

Founded in 2014 and ISO 9001-certified, Labfish specializes in providing an extensive array of laboratory equipment rentals, including scales, freezers, infusion pumps, and monitoring devices. Additionally, Labfish stands out for offering kitting services, ancillary supplies, and a robust in-house calibration expertise essential for supporting clinical trials. Its impressive network spans across various countries with established Importer of Record (IOR) and Exporter of Record (EOR) services, ensuring seamless logistics and supply chain management for clinical trial sites globally.

Strategic Acquisition Enhancing Clinical Trial Support

By integrating Labfish into its Equipment and Ancillaries (EA) division, Resonant aims to strengthen its ability to provide complex clinical trial support, addressing the increasing demand for specialized capabilities in research workflows. "Incorporating Labfish into Resonant's EA business extends our presence in Europe and enhances our calibration and import/export services," commented Christophe Berthoux, CEO of Resonant Clinical Solutions.

This acquisition signifies Resonant's commitment to evolving alongside its customers' needs, particularly as clinical trials become more complex and necessitate tailored logistical solutions. The partnership not only adds depth to Resonant's service portfolio but also enhances operational efficiency, enabling quicker responses to the rapidly changing landscape of clinical research.

Labfish's Expertise and Global Reach

Labfish, headquartered in Hamburg, operates one of Europe’s largest in-house calibration facilities, an asset that Resonant will leverage to bolster its capabilities in managing precise calibration needs for clinical trials. Furthermore, with partner depots located in Argentina, Israel, Turkey, and China, Labfish demonstrates a strong logistical network that will complement Resonant's existing infrastructure and facilitate clinical trial operations in over 70 countries.

Martin Forster, the Founder of Labfish, expressed optimism about the acquisition, stating, "Joining Resonant allows our team to further grow the calibration expertise and logistics services we’ve developed, while enhancing our capacity to support the clinical journey."

Meeting the Needs of Evolving Clinical Trials

As clinical trials grow more intricate, the need for advanced logistics, calibration, and specialized equipment is crucial. This acquisition allows Resonant to address these evolving requirements effectively. It enhances their strategic direction, offering clients not just equipment rentals but a full spectrum of clinical trial support services.

With over 850 employees working across the U.S., U.K., and Europe, Resonant is not new to streamlining complexities in the clinical supply chain. With a track record of supporting more than 2,500 clinical trials and managing over 100 million research assets, the company aims to empower its partners through comprehensive solutions that facilitate focus on scientific discovery and patient care.

This acquisition is set to enhance the value that Resonant Clinical Solutions delivers to its clients, creating a more robust framework that responds aptly to the demands of contemporary clinical trials. As it continues to expand its capabilities, Resonant remains focused on its mission to support life sciences organizations around the globe.

For further information, you can visit Resonant Clinical Solutions.